Christensen S - Search Results

1

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection.

von Felden J, Vermehren J, Ingiliz P, Mauss S, Lutz T, Simon KG, Busch HW, Baumgarten A, Schewe K, Hueppe D, Boesecke C, Rockstroh JK, Daeumer M, Luebke N, Timm J, Schulze Zur Wiesch J, Sarrazin C, Christensen S. von Felden J, et al. Among authors: christensen s. Aliment Pharmacol Ther. 2018 May;47(9):1288-1295. doi: 10.1111/apt.14592. Epub 2018 Mar 14. Aliment Pharmacol Ther. 2018. PMID: 29536554

2

Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the concept.

Obermeier M, Ingiliz P, Weitner L, Cordes C, Moll A, Hintsche B, Schlote F, Koeppe S, Christensen S, Mayr C, Baumgarten A. Obermeier M, et al. Among authors: christensen s. Eur J Med Res. 2011 May 12;16(5):237-42. doi: 10.1186/2047-783x-16-5-237. Eur J Med Res. 2011. PMID: 21719398 Free PMC article.

3

Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.

Reiberger T, Obermeier M, Payer BA, Baumgarten A, Weitner L, Moll A, Christensen S, Köppe S, Kundi M, Rieger A, Peck-Radosavljevic M. Reiberger T, et al. Among authors: christensen s. Antivir Ther. 2011;16(6):815-24. doi: 10.3851/IMP1831. Antivir Ther. 2011. PMID: 21900713

4

Chronic hepatitis C: treat or wait? Medical decision making in clinical practice.

Niederau C, Hüppe D, Zehnter E, Möller B, Heyne R, Christensen S, Pfaff R, Theilmeier A, Alshuth U, Mauss S. Niederau C, et al. Among authors: christensen s. World J Gastroenterol. 2012 Mar 28;18(12):1339-47. doi: 10.3748/wjg.v18.i12.1339. World J Gastroenterol. 2012. PMID: 22493547 Free PMC article.

5

Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohort.

Mauss S, Böker K, Buggisch P, Christensen S, Hofmann WP, Schott E, Pfeiffer-Vornkahl H, Alshuth U, Hüppe D. Mauss S, et al. Among authors: christensen s. Z Gastroenterol. 2015 Jul;53(7):644-54. doi: 10.1055/s-0034-1399383. Epub 2015 Jul 13. Z Gastroenterol. 2015. PMID: 26167694 Clinical Trial.

6

Chronic hepatitis C patients prior to broad access to interferon-free treatments in Germany.

Hüppe D, Buggisch P, Christensen S, Heiken H, Mauss S, Naumann U, Fischer C, Kleine H, Huelsenbeck J. Hüppe D, et al. Among authors: christensen s. Z Gastroenterol. 2016 Aug;54(8):740-7. doi: 10.1055/s-0042-106731. Epub 2016 Aug 16. Z Gastroenterol. 2016. PMID: 27529525 Clinical Trial. English.

7

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

Ingiliz P, Christensen S, Kimhofer T, Hueppe D, Lutz T, Schewe K, Busch H, Schmutz G, Wehmeyer MH, Boesecke C, Simon KG, Berger F, Rockstroh JK, Schulze zur Wiesch J, Baumgarten A, Mauss S. Ingiliz P, et al. Among authors: christensen s. Clin Infect Dis. 2016 Nov 15;63(10):1320-1324. doi: 10.1093/cid/ciw567. Epub 2016 Aug 17. Clin Infect Dis. 2016. PMID: 27535952 Clinical Trial.

8

Effect of antiviral therapy for HCV on lipid levels.

Mauss S, Berger F, Wehmeyer MH, Ingiliz P, Hueppe D, Lutz T, Simon KG, Schewe K, Rockstroh JK, Baumgarten A, Christensen S. Mauss S, et al. Among authors: christensen s. Antivir Ther. 2017;21(1):81-88. doi: 10.3851/IMP3094. Epub 2016 Sep 29. Antivir Ther. 2017. PMID: 27685337

9

Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study.

Wedemeyer H, Reimer J, Sandow P, Hueppe D, Lutz T, Gruengreiff K, Goelz J, Christensen S, Pfeiffer-Vornkahl H, Alshuth U, Manns MP. Wedemeyer H, et al. Among authors: christensen s. Liver Int. 2017 Oct;37(10):1468-1475. doi: 10.1111/liv.13399. Epub 2017 Jul 18. Liver Int. 2017. PMID: 28247572

10

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry.

Welzel TM, Hinrichsen H, Sarrazin C, Buggisch P, Baumgarten A, Christensen S, Berg T, Mauss S, Teuber G, Stein K, Deterding K, van Bömmel F, Heyne R, John C, Zimmermann T, Lutz T, Schott E, Hettinger J, Kleine H, König B, Hüppe D, Wedemeyer H. Welzel TM, et al. Among authors: christensen s. J Viral Hepat. 2017 Oct;24(10):840-849. doi: 10.1111/jvh.12708. Epub 2017 May 25. J Viral Hepat. 2017. PMID: 28342229

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,070 results

Search Page

Filters